Apparatus for Simulating a High Five
A self-righting hand-arm configuration which is adapted to pivot when struck by a user, thereby simulating a "high five."
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8013174 | Photochromic spirodihydrophenanthropyrans Specific photochromic spirodihydrophenanthropyrans and their use in synthetic resin materials of all kinds, particularly for ophthalmic purposes. The compounds of the invention are photochromic pyran compounds derived from 9,10-dihydrophenanthrene in which at least ... | 09/06/2011 |
| 7982057 | Compound of stemphones and production thereof The present invention relates to novel compound of stemphones obtained by culturing microorganism belonging to genus Aspergillus and having ability to produce compound of stemphones selected from the group consisting of stemphone D substance, stemphone E subs... | 07/19/2011 |
| 7365113 | Phosphate ester flame retardants from resorcinol-ketone reaction products Flavan-based and spirodichroman compound-based phosphate esters prepared by reacting flavans and spirodichroman compounds with phosphorus oxychloride, monophenyl dichlorophosphate, or diphenyl chlorophosphate compounds are described. The flavans and spirodichroman c... | 04/29/2008 |
| 7332260 | Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them The present invention relates to novel compounds of the naphthopyran type which have an annelated carbocycle in position 5,6. These compounds are of formula (I) given below: in which A is an alicyclic ring which ... | 02/19/2008 |
| 7326696 | Amino-methyl substituted tetracycline compounds Aminomethyl substituted tetracycline compounds, pharmaceutical compositions, and methods of use thereof are discussed. ... | 02/05/2008 |
| 7250120 | Benzo-, naphtho- and phenanthrochromene substituted by carbamated or ureated phenyls, preparation thereof and compositions and articles containing them Disclosed are novel benzo-, naphtho- and phenanthrochromenes substituted by carbamated or ureated phenyls having the following general formula (I): wherein R1 represents a group | 07/31/2007 |
| 7229576 | Substituted phenanthropyrans The present invention relates to specific photochromic phenanthropyrans as well as to their use in synthetic resin materials of all types, especially for ophthalmic purposes. In particular, the present invention relates to photochromic compounds derived from 2H-phen... | 06/12/2007 |
| 7157492 | Dibenzo chromene derivatives and their use as ERβ selective ligands This invention provides estrogen receptor modulators of formula I, having the structure where R1, R2, R3, R4, R5, R6, R7 and R8 | 01/02/2007 |
| 7147889 | Organic photochromic compositions of improved kinetic performance Described are imbibition compositions that incorporate kinetic enhancing additive(s) into photochromic polymeric host material. Kinetic enhancing additives include organic polyol(s), epoxy-containing compound(s) or a mixture thereof that improves the performance of ... | 12/12/2006 |
| 7138428 | Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same Disclosed herein are an acetone-extracted product obtained from gamboge resin and compounds further purified from said acetone-extracted product, including a new compound called formoxanthone A. The acetone-extracted product and the further purified compounds have b... | 11/21/2006 |
| 7074943 | Oxygen-containing heterocyclic fused naphthopyrans This invention relates to novel naphthopyrans having an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring, having certain substituents at the 2, 5, and 6 positions of the naphthopyran ring. These naphthopyrans may have ... | 07/11/2006 |
| 7036932 | Laminated functional wafer for plastic optical elements A functional wafer of the present invention is disclosed to solve manufacturing difficulties involved in the production of optical elements such as polycarbonate ophthalmic lenses. The functional wafer may include a front layer, a functional layer, and a back layer,... | 05/02/2006 |
| 7004583 | Eyewear lenses and methods of manufacturing Unfinished lenses, semi-finished lens including optical coatings or a transmission altering layer and methods of manufacturing are described. The unfinished lens includes an optical coating and a surface configured to receive a curve. Non-prescriptive and prescripti... | 02/28/2006 |
| 6963003 | Oxygen-containing heterocyclic fused naphthopyrans This invention relates to novel naphthopyrans having an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring, having certain substituents at the 2, 5, and 6 positions of the naphthopyran ring. These naphthopyrans may have ... | 11/08/2005 |
| 6936725 | Photochromic compounds A photochromic compound suitable for use as a single substance for photochromic tinting of a transparent plastic article so that the tinted article has a neutral gray or brown color in the excited state, is made by fusing at least two non-identical photochromic sect... | 08/30/2005 |
| 6781001 | Nucleic acids labelled with extended rhodamine dyes Extended rhodamine compounds exhibiting favorable fluorescence characteristics having the structure are disclosed. In addition, novel intermediates for synthesis of these dyes are disclosed, such intermediates having the... | 08/24/2004 |
| 6727277 | Compounds affecting cholesterol absorption A class of novel compounds is described for use in affecting lymphatic absorption of cholesterol. Compounds of particular interest are defined by Formula I: or a pharmaceutically acceptable salt thereof. ... | 04/27/2004 |
| 6723747 | Substituted 6H-DiBenzo[c,h]chromenes as estrogenic agents This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, R4 R5, R6, and R7 are as def... | 04/20/2004 |
| 6608215 | Oxygen-containing heterocyclic fused naphthopyrans Novel naphthopyrans having an oxygen-containing heterocyclic group F annelated on the f, i, j, or k side of the naphthopyran ring. These naphthopyrans may have the formula (I) presented below: ##STR1## These compounds (I) have interesting photochromic pro... | 08/19/2003 |
| 6608216 | Process for the preparation of chiral glucocorticoid receptor agents The present invention relates to the preparation of chiral glucocorticoid receptor agents via biaryl atropisomers.... | 08/19/2003 |
| 6503552 | Adding flavidin to a composition as an anti-oxidant The present invention relates to use of natural flavidin compound (2,7-dihydroxy 9,10-dihydrophenanthro-4,5 bcd-pyran) as an antioxidant in compositions comprising flavidin and other additives.... | 01/07/2003 |
| 6500936 | Pluraflavins and derivatives thereof, process for their preparation and use thereof The invention relates to a compound of formula (I) ##STR1## wherein R1 is a sugar; R2 is --CH2 --O--(R7)m, R7 representing a sugar, or is --COOH; R3 is an epoxide-comprising group, or is C | 12/31/2002 |
| 6398987 | Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them The present invention relates to novel compounds of the naphthopyran type which have a perfluoroalkyl group (X) in position 5. These compounds are of formula (I) given below: ##STR1## These compounds (I) possess interesting photochromic properties. The ... | 06/04/2002 |
| 6384045 | Tricyclic and tetracyclic pyrones This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone ring. The tricyclic oxypyrone synthetic method is a simple con... | 05/07/2002 |
| 6346536 | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same Poly(ADP-ribose) polymerase ("PARP") inhibitors and methods for treating neurodegenerative diseases, neural tissue damage related to cerebral ischemia and reperfusion injury, and cardiovascular in an animal.... | 02/12/2002 |
| 6342459 | Photochromic naphthopyrans The present invention relates to photochromic 2H-naphtho[1,2-b]pyrans as well as their use in synthetic resins of all types, especially for ophthalmic purposes. In particular, the present invention relates to photochromic naphthopyran compounds, for which... | 01/29/2002 |
| 6166066 | Cannabinoids selective for the CB2 receptor Disclosed are novel cannabinoids which are selective for the CB2 receptor. The novel cannabinoids comprise a substituted or unsubstituted tricyclic cannabinoid core and a substituted or unsubstituted C5-C8 carbocyclic ring, five to eight-membered heterocy... | 12/26/2000 |
| 6133288 | Pentacyclic compounds, intermediates, processes, compositions, and methods The present invention provides compounds of formula I and II: ##STR1## wherein X is --O--, --S--, or --NR5 --; Y is --O--, --S--, --CH2 --, --CH2 CH2 --, --CH.dbd.CH--, or --NR5 --; B is --CH2 | 10/17/2000 |
| 6106744 | Photochromic pyrano-fused naphthopyrans Described are novel photochromic pyrano-fused naphthopyran compounds, examples of which are naphthopyran compounds having a substituted or unsubstituted "S" pyran ring, the 3,4 positions of which are fused to the f side of the naphtho portion of the napht... | 08/22/2000 |
| 6087347 | 3-substituted-D-homo-1,3,5(10)-estratriene derivatives Estratriene derivatives of the following formula have a powerful inhibitory effect on estrone sulfatase and are hence useful for the prophylaxis or treatment of diseases caused by estrogens, such as breast cancer, uterine cancer, ovarian cancer, endometri... | 07/11/2000 |
| 5958970 | Tricyclic and tetracyclic pyrones This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone ring. The tricyclic oxyprone synthetic method is a simple cond... | 09/28/1999 |
| 5912362 | Process for preparing isochroman compounds High-purity isochroman compounds can be obtained in high yields according to a simple and economical process for preparing isochroman compounds, comprising the step of adding an aquesous solution of formaldehyde having a concentration of 40 to 70 wt. % to... | 06/15/1999 |
| 5888432 | 2-Adamantyl benzopyrans the compositions and (co)polymer matrices containing them The present invention has for subjects, novel benzopyran derivatives, substituted in position 2 with an adamantyl group as well as the compositions and (co)polymer matrices containing such derivatives. Said derivatives possess interesting photochromic pro... | 03/30/1999 |
| 5847168 | Photochromic compounds A photochromic article that includes a host material and a photochromic amount of a naphthopyran compound, the naphthopyran compound represented by the formula: ##STR1## wherein R1 ', R2 ', R3 ', R4 ', R | 12/08/1998 |
| 5840926 | Photochromic articles A photochromic article that includes a host material and a photochromic amount of a naphthopyran compound, the naphthopyran compound represented by the formula: ##STR1## wherein R1 ', R2 ', R3 ', R4 ', R | 11/24/1998 |
| 5789438 | Inhibitors of farnesyl-protein transferase The present invention is directed to steroidal or terpenoidal compounds which inhibit farnesyl-protein transferase (FPTase). The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhi... | 08/04/1998 |
| 5783116 | Derivatives of carbocyclic fused naphthopyrans Described are novel pentahydrophenanthro9,10-b!pyrans and tetrahydrocyclopentac!-naphtho1,2-b!pyrans. Also described are polymeric organic host materials that contain or that are coated with such compounds.... | 07/21/1998 |
| 5726186 | Pentacyclic compounds, intermediates, processes, compositions, and methods The present invention provides compounds of formula I: ##STR1## wherein X is --O-- or --S--, Y is --O--, --S--, --CH2 --, --CH2 CH2 --, --CH.dbd.CH--, or --NR5 --; R1, R2, and R3... | 03/10/1998 |
| 5723631 | Coumarin derivatives as retroviral inhibitors The present invention relates to a process for the preparation of a compound of the following structure: ##STR1## wherein, substituents are as defined in the specification.... | 03/03/1998 |
| 5674432 | Photochromic naphthopyran compounds Described are novel reversible photochromic diaryl-3H-naphtho2,1-b!pyran compounds having a substituted or unsubstituted, five or six member heterocyclic ring fused to the g, i, or l side of the naphthopyran. The heterocyclic ring contains an oxygen or ... | 10/07/1997 |